Mobilization of peripheral blood progenitor cells for allogeneic transplantation

Cytokines, Cellular and Molecular Therapy

Volumn 3, Issue 2, 1997, Pages 101-114

  Teshima, Takanori ^a   Harada, Mine ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Allotransplantation; CD34+ cells; G CSF; Mobilization; Peripheral blood stem progenitor cells

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 7; INTERLEUKIN 8; STEM CELL FACTOR; THROMBOPOIETIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL CELL; ARTICLE; BONE PAIN; CELL TRANSPLANTATION; CLINICAL TRIAL; COLONY FORMING UNIT GM; FEVER; HEADACHE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; META ANALYSIS; MONOCYTE; NAUSEA; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; VOMITING;

ANTIGENS, CD34; BLOOD DONORS; CELL COUNT; CYTOKINES; ETHICS, MEDICAL; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; KINETICS; LEUKAPHERESIS; LYMPHOCYTES; MONOCYTES; SAFETY; THROMBOCYTOPENIA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030766102     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (106)

1. Richman CM, Weiner RS, Yankee RA, Increase in circulating stem cells following chemotherapy in man. Blood (1976) 47: 1031-9.
2. Socinski MA, Canninstra SA, Elias A et al, Granulocyte-macrophage colony-stimulating factor expands the circulating hematopoietic cell compart-ment in humans. Lancet (1988) i: 1194-8.
3. Sheridan WP, Begley CG, Juttner CA et al, Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet (1992) 339: 640-6.
4. Teshima T, Harada M, Takamatsu Y et al, Cytotoxic drugs and cytotoxic drugs/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant (1992) 10: 215-20.
5. To LB, Roberts MM, Haylock DN et al, Comparison of hematological recovery times and supportive care requirements of peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant (1992) 9: 279-84.
6. Hartmann O, LeCarroller AG, Blaise D et al, Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs: a randomized, controlled trial. Ann Intern Med (1997) 126: 600-7.
7. Schmitz N, Linch DC, Dreger P et al, Randomised trial of filgrastim-mobilised blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet (1996) 347: 353-7.
8. Gratwohl A, Baldmero H, Hermans J, Haematopoietic precursor cell transplant activity in Europe 1994. Bone Marrow Transplant (1996) 17: 137-48.
9. Duhrsen U, Villeval JL, Boyd J et al, Effects of recombinant human granulocyte colony-stimulating factor in cancer patients. Blood (1988) 72: 2074-81.
10. Bensinger WI, Singer J, Appelbaum E et al, Autologous transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony stimulating factor. Blood (1993) 81: 3158-63.
11. Bensinger WI, Longin K, Appelbaum F et al, Peripheral blood stem cells (PBSCs) collected after recombinant human granulocyte colony stimulating factor (rhG-CSF) : an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol (1994) 87: 825-31.
12. Kessinger A, Smith DM, Strandjord WE et al, Allogeneic transplantation of blood-derived T-cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant (1989) 4: 643-6.
13. Weaver CH, Buckner CD, Longin K et al, Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony stimulating factor. Blood (1993) 82: 1981-4.
14. Dreger P, Suttorp M, Haferlach T et al, Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood (1993) 81: 1404-7.
15. Suzue T, Kawano Y, Takaue Y et al, Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor. Exp Hematol (1994) 22: 888-92.
16. + cell counts and on the collection of peripheral blood stem cells. Transfusion (1996) 36: 601-10.
17. Matsunaga T, Sakamaki S, Kohgo Y et al, Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant (1993) 11: 103-8.
18. Russel NH, Hunter A, Rogers S et al, Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet (1993) 341: 1482.
19. Schwinger W, Mache C, Urben C et al, Single dose of filgrastim (rhG-CSF) increases the number of hemopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplant (1993) 11:489-92.
20. Baumann I, Testa NG, Lange C et al, Haemopoietic cells mobilised into the peripheral blood using lenograstim as an alternative to bone marrow for allogeneic transplantation. Lancet (1993) 341: 369.
21. Dreger P, Haferlach T, Eckstein V et al, G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization and composition of the graft. Br J Hematol (1994) 87: 609-13.
22. Miflin G, Charley C, Stainer C et al, Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol (1996) 95: 345-8.
23. Harada M, Nagafuji K, Fujisaki T et al, G-CSF induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation. J Hematother (1996) 5: 63-71.
24. Stroncek DF, Clay ME, Smith J et al, Changes in blood counts after the administration of granulocyte colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion (1996) 36: 596-600.
25. Yano T, Katayama Y, Sunami K et al, G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF. Int J Hematol 66: (in press).
26. Waller CF, Bertz H, Wegener MK, Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplant (1996) 18: 279-83.
27. Russell JA, Luider J, Weaver M et al, Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant (1995) 15: 111-15.
28. Sato N, Sawada K, Takahashi TA et al, A time course study for optimal harvest of peripehral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp Hematol (1994) 22: 973-8.
29. Grigg AP, Roberts AW, Raunow H et al, Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilisation and collection of peripheral blood progenitor cells in normal volunteers. Blood (1995) 86: 4437-45.
30. Molineux G, Pojda Z, Hampson IN et al, Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood (1990) 76: 2153-7.
31. Gratwohl A, Baldomero H, John L et al, Transplantation of G-CSF mobilised peripheral blood stem cells in rabbits. Bone Marrow Transplant (1995) 16: 63-8.
32. Bensinger WI, Clift R, Martin P et al, Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood (1996) 88: 2794-800.
33. Kobling M, Przepiorka D, Huh YO et al, Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood (1995) 85: 1659-65.
34. Bensinger WI, Weaver CH, Appelbaum F et al, Transplantation of allogeneic peripheral blood stem cells mobilised by recombinant human granulocyte colony-stimulating factor. Blood (1995) 85: 1655-8.
35. Schmitz N, Dreger P, Suttorp M et al, Primary transplantation of allogeneic peripheral blood progenitor cells mobilised by filgrastim (granulocyte colonystimulating factor). Blood (1995) 85: 1666-72.
36. Bacigalupo A, Van Lint MT, Valbonesi M et al, Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. Blood (1996) 88: 353-7.
37. Rosenfeld C, Collins R, Pineiro L et al, Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study. J Clin Oncol (1996) 14:1314-19.
38. Bensinger WI, Clift RA, Anasetti C et al, Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colonystimulating factor. Stem Cells (1996) 14: 90-105.
39. Azevedo WM, Aranha FJ, Gouvea JV et al, Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant (1995) 16: 647-53.
40. Ottinger HD, Beelen DW, Scheulen B et al, Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood (1996) 88: 2775-9.
41. - peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony stimulating factor. Blood (1994) 84: 2795-801.
42. Huhn RD, Yurkow EJ, Tushinski R et al, Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol (1996) 24: 839-47.
43. + progenitor cell yields and lymphoid subsets in normal donors for allogeneic transplantation. Br J Haematol (1996) 93: 940-2.
44. dim) and lymphoid subsets and possible predictors of engraftment and graft-versus-host disease. Blood (1995) 86: 2842-8.
45. Korbling M, Chan KW, Anderlini P et al, Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatrie donors. Bone Marrow Transplant (1996) 18: 885-90.
46. + selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer. Blood (1997) 89: 1521-8.
47. Roberts AW, DeLuca E, Begley CG et al, Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells (1995) 13: 512-16.
48. Chatta GS, Price TH, Allen RC et al, Effects of recombinant methionyl human granulocyte colony stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult donors. Blood (1994) 84: 2923-9.
49. Bishop MR, Tarantolo SR, Jackson JD et al, Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor. J Clin Oncol (1997) 15: 1601-7.
50. Anderlini P, Lauppe J, Przepiorka D et al, Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections. Br J Haematol (1997) 96: 415-17.
51. Bender JG, To LB, Willans S et al, Defining a therapeutic dose of peripheral blood of stem cells. J Hematother (1992) 1: 329-41.
52. Russell N, Gratwohl A, Schmilz N, The place of blood stem cells in allogeneic transplantation. Br J Haematol (1996) 93: 747-53.
53. Prosper F, Stroncek D, Verfaillie, Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony stimulating factor. Blood (1996) 88: 2033-42.
54. + cells in cord blood and in cytokine-mobilized blood. Br J Haematol (1996) 92: 255-62.
55. + cells. Blood (1994) 84: 2930-9.
56. Rice A, Boiron JM, Baebot C et al, Cytokinemediated expansion of 5-FU-resistant peripheral blood stem cells. Exp Hematol (1995) 23: 303-8.
57. Fujisaki T, Otsuka T, Harada M et al, Granulocyte colony stimulating factor mobilizes primitive hematopoietic stem cells in normal individuals. Bone Marrow Transplant (1995) 16: 57-62.
58. Wang JCY, Doedens M, Dick JE, Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood (1997) 89: 3919-24
59. Briones J, Urbano-Ispizua A, Rozman C et al, Study of hemopoietic chimerism following allogeneic peripheral blood stem cell transplantation using PCR amplification of short tandem repeats. Ann Hematol (1996) 72: 265-8.
60. Lindemann A, Herrmann F, Oster W et al, Hematologie effects of recombinant human granulocyte colony-stimulating factor in patients with advanced malignancy. Blood (1989) 74: 2644-51.
61. Jones RJ, Celano P, Sharkis SJ et al, Two phases of engraftment established by serial bone marrow transplantation in mice. Blood (1989) 73: 397-401.
62. Turner ML, Sweetenham JW, Haemopoietic progenitor homing and mobilization. Br J Haematol (1996) 94: 592-6.
63. Papayannopoulou T, Nakamoto B, Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA (1993) 90: 9374-8.
64. + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood (1996) 87: 1644-53.
65. Roberts AW, Metcalf D, Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood (1995) 86: 1600-5.
66. Martinez C, Urban-Ispizua A, Mazzara R et al, Granulocyte colony-stimulating factor administration and peripheral blood progenitor cells collection in normal donors: analysis of leukapheresis-related side effects. Blood (1996) 87: 4916-17.
67. Anderlini P, Przepiorka D, Seong D et al, Clinical toxicity and laboratory effects of granulocyte colonystimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion (1996) 36: 590-5.
68. Weaver CH, Longin K, Buckner CD et al, Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony stimulating factor. Bone Marrow Transplant (1994) 13: 411-15.
69. Pan L, Delmonte J, Jalonen K et al, Pretreatment of donor mice with granulocyte colony-stimulating factor polarized donor T lymphocytes toward type-2 cytokine production and reduced severity of experimental graft-versus-host disease. Blood (1995) 86:4422-9.
70. Sandmaier BM, Storb R, Santos EB et al, Allogeneic transplants of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors. Blood (1996) 87: 3508-13.
71. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood (1991) 89: 1629-34.
72. + cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood (1996) 87: 574-80.
73. Bcnsinger WI, Price TH, Dale DC et al, The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood (1993) 81: 1883-8.
74. Majolino I, Buscemi F, Scime R et al, Treatment of normal donors with rhG-CSF 16 μg/kg for mobilization of peripheral blood stem cells and their apheretic collection for allogeneic transplantation. Haematologica (1995) 80: 219-26.
75. Anderlini P, Przepiorka D, Seong D et al, Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis. Br J Haematol (1996) 94: 155-8.
76. Conti JA, Sher HL, Acute arterial thrombosis after escalated-dose methotrexate, vincristine, doxorubicin, cisplatin chemotherapy with recombinant human granulocyte colony-stimulating factor. Cancer (1992) 70: 2699-702.
77. Kawachi Y, Watanabe A, Uchida T et al, Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor. Br J Haematol (1996) 94: 413-16.
78. Shimoda K, Okamura S, Harada M et al, Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest (1993) 91: 1310-13.
79. Shimoda K, Okamura S, Inaba S et al, Granulocyte colony-stimulating factor and platelet aggregation. Lancet (1993) 341: 633.
80. Kuroiwa M, Okamura T, Kanaji T et al, Effects of granulocyte colony-stimulating factor on hemostatic system in healthy volunteers. Int J Hematol (1996) 63: 311-16.
81. Parkkali T, Volin L, Siren M-K et al, Acute iritis induced by granulocyte colony-stimulating factor in a volunteer unrelated peripheral blood progenitor cell donor. Bone Marrow Transplant (1996) 17: 433-4.
82. Anderlini P, Przepiorka D, Champlin R et al, Peripheral blood stem cell apheresis in normal donors: the neglected side. Blood (1996) 88: 3663-4.
83. Darrington DL, Vose JM, Anderson JR et al, Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol (1994) 12: 2527-33.
84. Sakamaki S, Matsunaga T, Hirayama Y et al, Haematological study of healthy volunteers 5 years after G-CSF. Lancet (1995) 346: 1432-3.
85. Buckner CD, Peterson FB, Bolonesi BA, Bone marrow donors. In: Bone Marrow Transplantation (ed SJ Forman, KG Blume, ED Thomas) 259-69. Blackwell Scientific Publications, Cambridge, MA, 1994.
86. Lane TA, Law P, Maruyama M et al, Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood (1995) 85: 275-82.
87. Winter JN, Lazarus HM, Rademaker A et al, Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells. J Clin Oncol (1996) 14: 277-86.
88. Andrews RG, Briddell RA, Knitter GH et al, In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony stimulating factor in baboons: enhanced circulation of progenitor cells. Blood (1994) 84: 800-10.
89. Andrews RG, Briddell RA, Knitter GH et al, Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony stimulating factor in nonhuman primate. Blood (1995) 85: 15-20.
90. Weaver A, Ryder D, Crowther D et al, Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony stimulating factor. Blood (1996) 88: 3323-8.
91. Laterveer L, Lindley IJD, Hamilton MS et al, Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood (1995) 85: 2269-75.
92. Laterveer L, Lindley IJD, Heemskerk et al, Rapid mobilization of hematopoietic progenitor cells in rhesus monkey by a single intravenous injection of interleukin-8. Blood (1996) 87: 781-8.
93. Caver-Moore K, Broxmeyer HE, Louh S et al, Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice. Blood (1996) 88: 803-8.
94. Mauch P, Lamont C, Neben TY et al, Hematopoietic stern cells in the blood after stem cell factor and interleukin-11 administration: evidence for different mechanisms of mobilization. Blood (1995) 86: 4674-80.
95. Grzegorzewski KJ, Komschlies KL, Jacobsen SE et al, Mobilization of long-term reconstituting hematopoietic stem cells in mice by recombinant human interleukin-7. J Exp Med (1995) 181: 369-74.
96. De Revel T, Appelbaum FR, Storb R et al, Effects of granulocyte colony stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood (1994) 83: 3795-9.
97. McNiece IK, Briddell RA, Stem cell factor. J Leukoc Biol (1995) 57: 14-22.
98. Molineux G, Hartley C, McElroy P et al, Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. Blood (1996) 88: 366-76.
99. Fritsch G, Fischmeister G, Haas OA et al, Peripheral blood hematopoietic progenitor cells of cytokinestimulated donors as an alternative for allogeneic transplantation. Blood (1994) 83: 3420-1.
100. Moskowitz CH, Stiff P, Gordon MS et al, Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients - results of a phase I/II trial. Blood (1997) 89: 3136-47.
101. Molineux G, McCrea C, Yan XQ et al, Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potentials. Blood (1997) 89: 3998-4004.
102. Goan S-R, Fichtner I, Just U et al, The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis. Blood (1995) 86:89-100.
103. Aversa F, Tabilio A, Terenzi A et al, Successful cngrafrmcnt of T-cell-deplcted haploidentical 'threeloci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood (1994) 11: 3948-55.
104. + selection systems or CAMPATH-I. Exp Hematol (1995) 23: 147-54.
105. + blood cells. Blood (1996) 87: 4903-9.
106. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood (1996) 88: 4132-8.